Neoadjuvant combination immunotherapy in MSI/dMMR colorectal cancer

被引：0
|
作者：
Suarez-Carmona, Meggy [1 ,2 ]
Halama, Niels [1 ,2 ,3 ,4 ]
机构：
[1] German Canc Res Ctr, Dept Canc Immunol & Canc Immunotherapy, Heidelberg, Germany
[2] Helmholtz Inst Translat Oncol HI TRON, Mainz, Germany
[3] Johannes Gutenberg Univ Mainz, Univ Canc Ctr Mainz UCT Mainz, Univ Med Ctr, Mainz, Germany
[4] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Hematol Med Oncol & Pneumol, Mainz, Germany
来源：
TRENDS IN CANCER | 2024年 / 10卷 / 12期
关键词：
MISMATCH REPAIR-DEFICIENT; NIVOLUMAB;
D O I：
10.1016/j.trecan.2024.10.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Neoadjuvant immune checkpoint inhibition (ICI) is a new approach to treat patients with colorectal cancer (CRC). The effects of combined neoadjuvant ICI in locally advanced, DNA mismatch repair (dMMR)-deficient/microsatellite instable (MSI) CRC were recently reported by de Gooyer et al. from the NICHE-3 trial. Further studies will determine whether these impressive pathological responses lead to long-term clinical benefit.
引用
收藏
页码：1093 / 1094
页数：2
相关论文
共 50 条
  • [21] Serial ctDNA monitoring during immunotherapy (IO) in patients (pts) with MSI-H/dMMR advanced colorectal cancer (CRC)
    Somer, B.
    Mehler, S.
    Greene, H.
    Tauer, K.
    Somer, S.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S123 - S123
  • [22] Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
    Mulet-Margalef, Nuria
    Linares, Jenniffer
    Badia-Ramentol, Jordi
    Jimeno, Mireya
    Monte, Carolina Sanz
    Mozo, Jose Luis Manzano
    Calon, Alexandre
    CANCERS, 2023, 15 (04)
  • [23] NIVOLUMAB HAS ANTITUMOR ACTIVITY IN DMMR/MSI-H COLORECTAL CANCER
    CANCER DISCOVERY, 2017, 7 (09) : 930 - 930
  • [24] Immunotherapy outcomes in dMMR/MSI-H and/or TMB-H metastatic colorectal cancer (CRC) with peritoneal metastases (PM).
    Mosalem, Osama M.
    Elhariri, Ahmed
    Wiest, Nathaniel Edward
    Kamatham, Saivaishnavi
    Abdel-Razeq, Nayef Hikmat
    Jones, Jeremy Clifton
    Sonbol, Mohamad B.
    Jin, Zhaohui
    Babiker, Hani M.
    Bekaii-Saab, Tanios S.
    Majeed, Umair
    Starr, Jason S.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 163 - 163
  • [25] Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature
    San-Roman-Gil, Maria
    Martinez-Delfrade, Inigo
    Albarran-Fernandez, Victor
    Guerrero-Serrano, Patricia
    Pozas-Perez, Javier
    Chamorro-Perez, Jesus
    Rosero-Rodriguez, Diana
    Sotoca-Rubio, Pilar
    Barrill-Corpa, Ana Maria
    Alia-Navarro, Victor
    Gonzalez-Merino, Carlos
    Garcia-de-Quevedo-Suero, Coral
    Lopez, Victoria
    Ruz-Caracuel, Ignacio
    Perna-Monroy, Cristian
    Ferreiro-Monteagudo, Reyes
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [26] Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response
    Williams, Christopher J. M.
    Peddle, Allyson M.
    Kasi, Pashtoon M.
    Seligmann, Jenny F.
    Roxburgh, Campbell S.
    Middleton, Gary M.
    Tejpar, Sabine
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (12) : 839 - 851
  • [27] IMHOTEP phase II trial of neoadjuvant pembrolizumab in dMMR/MSI localized cancers: Results of the digestive non-colorectal cancer cohorts
    de la Fouchardiere, C.
    Zaanan, A.
    Cohen, R.
    Le Sourd, S. M.
    Tougeron, D.
    Soularue, E.
    Dubreuil, O.
    Williet, N.
    Samalin-Scalzi, E.
    Piessen, G.
    Hautefeuille, V.
    Jary, M.
    Ben Abdelghani, M.
    Evesque, L.
    Rochigneux, P.
    Blanc, E.
    Bibeau, F.
    DeMontfort, A.
    Coutzac, C.
    ANNALS OF ONCOLOGY, 2024, 35 : S899 - S900
  • [28] Introducing Neoadjuvant Immunotherapy for Colorectal Cancer
    Orhan, Adile
    Justesen, Tobias F.
    Raskov, Hans
    Qvortrup, Camilla
    Gogenur, Ismail
    ANNALS OF SURGERY, 2025, 281 (01) : 95 - 104
  • [29] Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trial
    Coutzac, Clelia
    Bibeau, Frederic
    Ben Abdelghani, Meher
    Aparicio, Thomas
    Cohen, Romain
    Coquan, Elodie
    Dubreuil, Olivier
    Evesque, Ludovic
    Ghiringhelli, Francois
    Kim, Stefano
    Lesourd, Samuel
    Neuzillet, Cindy
    Phelip, Jean-Marc
    Piessen, Guillaume
    Rochigneux, Philippe
    Samalin, Emmanuelle
    Soularue, Emilie
    Touchefeu, Yann
    Tougeron, David
    Zaanan, Aziz
    de la Fouchardiere, Christelle
    DIGESTIVE AND LIVER DISEASE, 2022, 54 (10) : 1335 - 1341
  • [30] Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer
    Bui, Quang Loc
    Mas, Leo
    Hollebecque, Antoine
    Tougeron, David
    de la Fouchardiere, Christelle
    Pudlarz, Thomas
    Alouani, Emily
    Guimbaud, Rosine
    Taieb, Julien
    Andre, Thierry
    Colle, Raphael
    Cohen, Romain
    CANCERS, 2022, 14 (02)
12345